Evidence summaries: unlicensed and off-label medicines – Interim process statement

  • NICE process and methods
  • PMG2
  • Published: 
Download (PDF)

Overview

This interim process statement sets out to guide the development of 'Evidence summaries: unlicensed and off-label medicines' (ESUOMs). It provides an overview of the key process principles and describes all stages of development for ESUOMs.

This is not the current process. From May 2013, ESUOMs were developed using using the integrated process statement.

Last reviewed: 7 August 2012